[
  {
    "ts": null,
    "headline": "How is Teladoc Health Placed in the Growing Telemedicine Market?",
    "summary": "Teladoc Health is expanding its AI-powered virtual care capabilities as the telemedicine market surges toward massive U.S. growth.",
    "url": "https://finnhub.io/api/news?id=22784203bf5f51655c05aaf3d33c7cddbac70826802f73a074a15132833e0394",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762796820,
      "headline": "How is Teladoc Health Placed in the Growing Telemedicine Market?",
      "id": 137437578,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Teladoc Health is expanding its AI-powered virtual care capabilities as the telemedicine market surges toward massive U.S. growth.",
      "url": "https://finnhub.io/api/news?id=22784203bf5f51655c05aaf3d33c7cddbac70826802f73a074a15132833e0394"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health (CVS): Assessing Fair Value After Goodwill Impairment, Q3 Loss, and Revised Outlook",
    "summary": "CVS Health (CVS) recently posted a net loss for the third quarter, cut full-year earnings guidance, and reported a major goodwill impairment. These developments have investors rethinking the company’s near-term outlook and business momentum. See our latest analysis for CVS Health. While CVS Health’s hefty goodwill impairment and reduced earnings outlook have weighed on sentiment, the 20.6% share price return over the last 90 days suggests some investors see value after a tough stretch. Total...",
    "url": "https://finnhub.io/api/news?id=c3ca83ee451b7e68eba2a0033597fc8e69f1d28b36a84b1c9fa28316964aa32a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762787641,
      "headline": "CVS Health (CVS): Assessing Fair Value After Goodwill Impairment, Q3 Loss, and Revised Outlook",
      "id": 137396717,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) recently posted a net loss for the third quarter, cut full-year earnings guidance, and reported a major goodwill impairment. These developments have investors rethinking the company’s near-term outlook and business momentum. See our latest analysis for CVS Health. While CVS Health’s hefty goodwill impairment and reduced earnings outlook have weighed on sentiment, the 20.6% share price return over the last 90 days suggests some investors see value after a tough stretch. Total...",
      "url": "https://finnhub.io/api/news?id=c3ca83ee451b7e68eba2a0033597fc8e69f1d28b36a84b1c9fa28316964aa32a"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Generative AI Powers October E-Commerce Spending",
    "summary": "Adobe (ADBE) says U.S. online spending rose 8.2% year-over-year in October to $88.7 billion.",
    "url": "https://finnhub.io/api/news?id=dce4f4231faca8f9bae441f731fdbb91b49bee3e3629e999aca01894e710bf46",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762786428,
      "headline": "Wall Street Lunch: Generative AI Powers October E-Commerce Spending",
      "id": 137400733,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2227981382/image_2227981382.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Adobe (ADBE) says U.S. online spending rose 8.2% year-over-year in October to $88.7 billion.",
      "url": "https://finnhub.io/api/news?id=dce4f4231faca8f9bae441f731fdbb91b49bee3e3629e999aca01894e710bf46"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health to hold Investor Day on December 9, 2025",
    "summary": "CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide financial guidance for 2025 and 2026.",
    "url": "https://finnhub.io/api/news?id=76eb2bf550043482256243eac561d661a1fa1cc846c4d8518e175062b9f7f718",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762783200,
      "headline": "CVS Health to hold Investor Day on December 9, 2025",
      "id": 137395078,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide financial guidance for 2025 and 2026.",
      "url": "https://finnhub.io/api/news?id=76eb2bf550043482256243eac561d661a1fa1cc846c4d8518e175062b9f7f718"
    }
  },
  {
    "ts": null,
    "headline": "TRIP, The World's Leading Calming Drinks Brand, Raises $40 Million",
    "summary": "TRIP announces a $40 million funding round – led by high-profile names such as Joe Jonas, Alessandra Ambrosio, Paul Wesley, Ashley Graham, and consumer fund Coefficient Capital. TRIP, the fastest growing drinks brand in the US this year (Spins) is on track to deliver $100 million in annual revenue this year and is predicted to reach $200 million in 2026.",
    "url": "https://finnhub.io/api/news?id=7c7ca89ebf98024a3571b68452d34138cbfb27dcf499271fec4ac8da3deffa58",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762781580,
      "headline": "TRIP, The World's Leading Calming Drinks Brand, Raises $40 Million",
      "id": 137395079,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "TRIP announces a $40 million funding round – led by high-profile names such as Joe Jonas, Alessandra Ambrosio, Paul Wesley, Ashley Graham, and consumer fund Coefficient Capital. TRIP, the fastest growing drinks brand in the US this year (Spins) is on track to deliver $100 million in annual revenue this year and is predicted to reach $200 million in 2026.",
      "url": "https://finnhub.io/api/news?id=7c7ca89ebf98024a3571b68452d34138cbfb27dcf499271fec4ac8da3deffa58"
    }
  },
  {
    "ts": null,
    "headline": "How the Changing Story Could Impact CVS Health’s Valuation and Growth Prospects",
    "summary": "CVS Health stock has recently seen its Fair Value Estimate rise from $86.20 to $91.52, reflecting increased confidence in the company's near-term earnings outlook. This price target adjustment follows strong quarterly results and sector trends, which indicate both momentum and ongoing market challenges. Stay tuned for strategies on how to keep up with the evolving narrative around CVS Health’s valuation and prospects. Analyst Price Targets don't always capture the full story. Head over to our...",
    "url": "https://finnhub.io/api/news?id=6b1dbb3f28c4a9711a25982126c5994fb92211d9cef4b3e0410c3135b2264f6e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762780222,
      "headline": "How the Changing Story Could Impact CVS Health’s Valuation and Growth Prospects",
      "id": 137395080,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health stock has recently seen its Fair Value Estimate rise from $86.20 to $91.52, reflecting increased confidence in the company's near-term earnings outlook. This price target adjustment follows strong quarterly results and sector trends, which indicate both momentum and ongoing market challenges. Stay tuned for strategies on how to keep up with the evolving narrative around CVS Health’s valuation and prospects. Analyst Price Targets don't always capture the full story. Head over to our...",
      "url": "https://finnhub.io/api/news?id=6b1dbb3f28c4a9711a25982126c5994fb92211d9cef4b3e0410c3135b2264f6e"
    }
  }
]